Why the study?
Does the presence of anticardiolipin antibodies predict recurrent cardiac events in patients with acute coronary syndrome?
Does the presence of anticardiolipin antibodies predict recurrent cardiac events in patients with acute coronary syndrome?
Elevated anticardiolipin antibodies in patients with acute coronary syndrome are associated with a significantly higher risk of restenosis after PCI, though not with increased mortality or reinfarction.
No takes yet. Share an insight, caveat, or question.
Anticardiolipin positivity may flag higher post-PCI restenosis risk in ACS; leaves open whether testing should guide care or requires prospective validation.
Gürlek et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: